Women's Health

The demand for self-managed medication abortions increased substantially after the abortion law S.B. 8 went into effect in Texas, according to findings published in JAMA Network Open.

Abdominal obesity is a risk factor for COPD and asthma among premenopausal and postmenopausal women in South Korea, according to study findings published in Menopause.

Women with a history of ductal carcinoma in situ reported confusion and concern about diagnosis and treatment of the noninvasive breast condition, according to results of a national web-based survey published in Cancer.

Researchers reported substantial variability in information on sex-based differences in drug safety and efficacy across trial publications and FDA sources for medications that were approved in 2019 and 2020.

Use of aspirin failed to prolong invasive DFS among patients with breast cancer, according to results of a randomized phase 3 study presented during the ASCO Plenary Series.

In 2019, most U.S. women who gave birth did not have favorable cardiometabolic health before pregnancy, researchers reported in a Go Red for Women spotlight edition of Circulation.

Breast cancer has surpassed lung cancer as the leading cause of cancer-associated death among Black women in the U.S., according to an American Cancer Society report.

Selinexor prolonged PFS compared with placebo among women with advanced or recurrent endometrial cancer, according to topline data released by the agent’s manufacturer.

Trametinib should be a new standard of care for women with recurrent low-grade serous carcinoma, according to study published in The Lancet that showed a 52% reduction in risk for disease progression or death vs. current treatment options.

The more steps that older women took per day, the more they lowered their risk for developing type 2 diabetes, according to findings published in Diabetes Care.